ILEC Conference Center and IBIS London Earls Court
47 Lillie Road
In the past decade, many scientific breakthroughs have been achieved in the treatment of cancer through basic research. This meeting will discuss that latest paradigm shift: personalised immunotherapies in combination with other drugs for the treatment of cancer. This shift is taking place against a backdrop of the development and regulatory approval of new monoclonal antibodies, cancer vaccines, adoptive cell therapies and immune-checkpoint therapies.